The anesthesia and respiratory devices market size has grown rapidly in recent years. It will grow from $37.63 billion in 2025 to $42.45 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to rising prevalence of respiratory disorders, expansion of hospital critical care infrastructure, increased surgical procedure volumes, wider availability of respiratory diagnostic tools, growth in disposable medical device usage.
The anesthesia and respiratory devices market size is expected to see rapid growth in the next few years. It will grow to $70.71 billion in 2030 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory care, rising investments in smart hospital technologies, growing demand for minimally invasive anesthesia delivery, expansion of remote patient monitoring solutions, increasing focus on personalized respiratory therapies. Major trends in the forecast period include increasing adoption of connected respiratory monitoring devices, rising demand for portable and home-based respiratory equipment, growing integration of smart anesthesia delivery systems, expansion of single-use respiratory disposables, enhanced focus on patient safety and infection control.
The rising prevalence of respiratory diseases is anticipated to drive the growth of the anesthesia and respiratory devices market. Respiratory diseases refer to medical conditions that disrupt breathing and gas exchange by impacting the lungs and airway systems. Anesthesia and respiratory equipment are essential in treating respiratory diseases like tuberculosis, as they facilitate necessary medical procedures, ensure patient comfort and safety, and assist in monitoring and managing the condition. For instance, in June 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, emergency admissions for respiratory diseases in England increased by 7% from the financial year ending 2023 to 2024, with COPD cases rising 9%, adult asthma 17%, and pneumonia 16% during the same period. Consequently, the increased prevalence of respiratory diseases is expected to propel the growth of the anesthesia and respiratory devices market in the future.
Rising healthcare expenditures are expected to drive the growth of the anesthesia and respiratory devices market. Healthcare expenditures encompass the total amount spent on healthcare-related services, products, and activities over a specified period, whether at the individual, community, national, or global level. As healthcare spending increases, there is generally a stronger focus on providing high-quality healthcare services, including surgical and respiratory care, leading to a demand for advanced devices that can improve patient outcomes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, National Health Expenditure (NHE) increased by 7.5% to $4.9 trillion in 2023, or $14,570 per person, representing 17.6% of Gross Domestic Product (GDP). Hospital expenditures rose 10.4% to $1.51 trillion in 2023, outpacing the 3.2% growth recorded in 2022. Therefore, the rise in healthcare spending is driving increased demand for healthcare services and related medical technologies. Therefore, the increase in healthcare expenditures is expected to propel the growth of the anesthesia and respiratory devices market in the coming years.
Major companies in the anesthesia and respiratory devices market are developing advanced solutions, such as low- and minimal-flow anesthesia optimization, to improve patient safety and operational efficiency. Low- and minimal-flow anesthesia optimization reduces anesthetic agent consumption by recycling sampled breathing gas and maintaining efficient delivery in real time, helping hospitals lower costs and reduce environmental impact. For instance, in September 2023, Dräger, a Germany-based medical and safety technology company, launched the Atlan anesthesia workstation family. The platform features a precision ventilation system and comprehensive safety functions for intraoperative care, delivering safe and precise ventilation from neonates to adults. It offers customizable workstation configurations, supports efficient hygiene with quick disassembly and smooth surfaces, and integrates with Dräger Connect to provide visibility into clinical and operational metrics, enhancing care quality and resource management.
Major companies operating in the anesthesia and respiratory devices market are Drägerwerk AG & Co KGaA, GE Healthcare, Koninklijke Philips N V, Medtronic plc, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical plc, Masimo Corporation, B Braun Melsungen AG, Shenzhen Mindray Bio‑Medical Electronics Co Ltd, Hamilton Medical AG, Nihon Kohden Corporation, Ambu A S, Invacare Corporation, SunMed Medical, Intersurgical Ltd, PARI GmbH, Heinen + Löwenstein GmbH & Co KG, Aerogen Ltd, DeVilbiss Healthcare LLC.
Asia-Pacific was the largest region in the global anesthesia and respiratory devices market in 2025. North America was the second largest region in the global anesthesia and respiratory devices market. Eastern Europe was the smallest region in the global anesthesia and respiratory devices market. The regions covered in the anesthesia and respiratory devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anesthesia and respiratory devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the anesthesia and respiratory devices market by increasing costs of imported sensors, ventilator components, anesthesia delivery systems, electronic control units, and disposable medical-grade plastics. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported critical care equipment, while Asia-Pacific faces pricing pressure on export-oriented device manufacturing. These tariffs are raising procurement costs and delaying equipment upgrades in healthcare facilities. However, they are also encouraging domestic manufacturing, localized supply chains for disposables, and increased investment in regional medical device production capabilities.
The anesthesia and respiratory devices market research report is one of a series of new reports that provides anesthesia and respiratory devices market statistics, including anesthesia and respiratory devices industry global market size, regional shares, competitors with a anesthesia and respiratory devices market share, detailed anesthesia and respiratory devices market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia and respiratory devices industry. This anesthesia and respiratory devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Anesthesia and respiratory devices play a vital role in the diagnosis and treatment of respiratory diseases, providing essential support for patients with conditions such as asthma, cystic fibrosis, acute respiratory distress syndrome, and others. This market encompasses a range of respiratory devices used to deliver medication and manage respiratory conditions.
The main types of anesthesia and respiratory devices include respiratory devices and equipment (both therapeutic and diagnostic), anesthesia machines, anesthesia disposables, and respiratory disposables. Respiratory disposables are designed for single-use and are discarded after factors such as excessive breathing resistance, sorbent exhaustion, physical damage, or the end of their service life makes them unsuitable for further use. Expenditure in this market can be categorized as public and private, and the products used include instruments/equipment and disposables. The utilization of these devices spans across various genders, including both male and female, and they find application in multiple end-user settings such as hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The anesthesia and respiratory devices market consists of sales of instruments such as resuscitators, laryngoscopes, flexible intubation scopes, supraglottic airways, ventilator circuits, HME, and other anesthesia and respiratory instruments that are used for the diagnosis and treatment of respiratory diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The anesthesia and respiratory devices market size is expected to see rapid growth in the next few years. It will grow to $70.71 billion in 2030 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory care, rising investments in smart hospital technologies, growing demand for minimally invasive anesthesia delivery, expansion of remote patient monitoring solutions, increasing focus on personalized respiratory therapies. Major trends in the forecast period include increasing adoption of connected respiratory monitoring devices, rising demand for portable and home-based respiratory equipment, growing integration of smart anesthesia delivery systems, expansion of single-use respiratory disposables, enhanced focus on patient safety and infection control.
The rising prevalence of respiratory diseases is anticipated to drive the growth of the anesthesia and respiratory devices market. Respiratory diseases refer to medical conditions that disrupt breathing and gas exchange by impacting the lungs and airway systems. Anesthesia and respiratory equipment are essential in treating respiratory diseases like tuberculosis, as they facilitate necessary medical procedures, ensure patient comfort and safety, and assist in monitoring and managing the condition. For instance, in June 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, emergency admissions for respiratory diseases in England increased by 7% from the financial year ending 2023 to 2024, with COPD cases rising 9%, adult asthma 17%, and pneumonia 16% during the same period. Consequently, the increased prevalence of respiratory diseases is expected to propel the growth of the anesthesia and respiratory devices market in the future.
Rising healthcare expenditures are expected to drive the growth of the anesthesia and respiratory devices market. Healthcare expenditures encompass the total amount spent on healthcare-related services, products, and activities over a specified period, whether at the individual, community, national, or global level. As healthcare spending increases, there is generally a stronger focus on providing high-quality healthcare services, including surgical and respiratory care, leading to a demand for advanced devices that can improve patient outcomes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, National Health Expenditure (NHE) increased by 7.5% to $4.9 trillion in 2023, or $14,570 per person, representing 17.6% of Gross Domestic Product (GDP). Hospital expenditures rose 10.4% to $1.51 trillion in 2023, outpacing the 3.2% growth recorded in 2022. Therefore, the rise in healthcare spending is driving increased demand for healthcare services and related medical technologies. Therefore, the increase in healthcare expenditures is expected to propel the growth of the anesthesia and respiratory devices market in the coming years.
Major companies in the anesthesia and respiratory devices market are developing advanced solutions, such as low- and minimal-flow anesthesia optimization, to improve patient safety and operational efficiency. Low- and minimal-flow anesthesia optimization reduces anesthetic agent consumption by recycling sampled breathing gas and maintaining efficient delivery in real time, helping hospitals lower costs and reduce environmental impact. For instance, in September 2023, Dräger, a Germany-based medical and safety technology company, launched the Atlan anesthesia workstation family. The platform features a precision ventilation system and comprehensive safety functions for intraoperative care, delivering safe and precise ventilation from neonates to adults. It offers customizable workstation configurations, supports efficient hygiene with quick disassembly and smooth surfaces, and integrates with Dräger Connect to provide visibility into clinical and operational metrics, enhancing care quality and resource management.
Major companies operating in the anesthesia and respiratory devices market are Drägerwerk AG & Co KGaA, GE Healthcare, Koninklijke Philips N V, Medtronic plc, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical plc, Masimo Corporation, B Braun Melsungen AG, Shenzhen Mindray Bio‑Medical Electronics Co Ltd, Hamilton Medical AG, Nihon Kohden Corporation, Ambu A S, Invacare Corporation, SunMed Medical, Intersurgical Ltd, PARI GmbH, Heinen + Löwenstein GmbH & Co KG, Aerogen Ltd, DeVilbiss Healthcare LLC.
Asia-Pacific was the largest region in the global anesthesia and respiratory devices market in 2025. North America was the second largest region in the global anesthesia and respiratory devices market. Eastern Europe was the smallest region in the global anesthesia and respiratory devices market. The regions covered in the anesthesia and respiratory devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anesthesia and respiratory devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the anesthesia and respiratory devices market by increasing costs of imported sensors, ventilator components, anesthesia delivery systems, electronic control units, and disposable medical-grade plastics. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported critical care equipment, while Asia-Pacific faces pricing pressure on export-oriented device manufacturing. These tariffs are raising procurement costs and delaying equipment upgrades in healthcare facilities. However, they are also encouraging domestic manufacturing, localized supply chains for disposables, and increased investment in regional medical device production capabilities.
The anesthesia and respiratory devices market research report is one of a series of new reports that provides anesthesia and respiratory devices market statistics, including anesthesia and respiratory devices industry global market size, regional shares, competitors with a anesthesia and respiratory devices market share, detailed anesthesia and respiratory devices market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia and respiratory devices industry. This anesthesia and respiratory devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Anesthesia and respiratory devices play a vital role in the diagnosis and treatment of respiratory diseases, providing essential support for patients with conditions such as asthma, cystic fibrosis, acute respiratory distress syndrome, and others. This market encompasses a range of respiratory devices used to deliver medication and manage respiratory conditions.
The main types of anesthesia and respiratory devices include respiratory devices and equipment (both therapeutic and diagnostic), anesthesia machines, anesthesia disposables, and respiratory disposables. Respiratory disposables are designed for single-use and are discarded after factors such as excessive breathing resistance, sorbent exhaustion, physical damage, or the end of their service life makes them unsuitable for further use. Expenditure in this market can be categorized as public and private, and the products used include instruments/equipment and disposables. The utilization of these devices spans across various genders, including both male and female, and they find application in multiple end-user settings such as hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The anesthesia and respiratory devices market consists of sales of instruments such as resuscitators, laryngoscopes, flexible intubation scopes, supraglottic airways, ventilator circuits, HME, and other anesthesia and respiratory instruments that are used for the diagnosis and treatment of respiratory diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Anesthesia and Respiratory Devices Market Characteristics
3. Anesthesia and Respiratory Devices Market Supply Chain Analysis
4. Global Anesthesia and Respiratory Devices Market Trends and Strategies
5. Anesthesia and Respiratory Devices Market Analysis of End Use Industries
7. Global Anesthesia and Respiratory Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Anesthesia and Respiratory Devices Total Addressable Market (TAM) Analysis for the Market
9. Anesthesia and Respiratory Devices Market Segmentation
10. Anesthesia and Respiratory Devices Market Regional and Country Analysis
11. Asia-Pacific Anesthesia and Respiratory Devices Market
12. China Anesthesia and Respiratory Devices Market
13. India Anesthesia and Respiratory Devices Market
14. Japan Anesthesia and Respiratory Devices Market
15. Australia Anesthesia and Respiratory Devices Market
16. Indonesia Anesthesia and Respiratory Devices Market
17. South Korea Anesthesia and Respiratory Devices Market
18. Bangladesh Anesthesia and Respiratory Devices Market
19. Thailand Anesthesia and Respiratory Devices Market
20. Vietnam Anesthesia and Respiratory Devices Market
21. Malaysia Anesthesia and Respiratory Devices Market
22. Singapore Anesthesia and Respiratory Devices Market
23. Philippines Anesthesia and Respiratory Devices Market
24. Hong Kong Anesthesia and Respiratory Devices Market
25. New Zealand Anesthesia and Respiratory Devices Market
26. Taiwan Anesthesia and Respiratory Devices Market
27. South East Asia Anesthesia and Respiratory Devices Market
28. Western Europe Anesthesia and Respiratory Devices Market
29. UK Anesthesia and Respiratory Devices Market
30. Germany Anesthesia and Respiratory Devices Market
31. France Anesthesia and Respiratory Devices Market
32. Italy Anesthesia and Respiratory Devices Market
33. Spain Anesthesia and Respiratory Devices Market
34. Austria Anesthesia and Respiratory Devices Market
35. Belgium Anesthesia and Respiratory Devices Market
36. Denmark Anesthesia and Respiratory Devices Market
37. Finland Anesthesia and Respiratory Devices Market
38. Ireland Anesthesia and Respiratory Devices Market
39. Netherlands Anesthesia and Respiratory Devices Market
40. Norway Anesthesia and Respiratory Devices Market
41. Portugal Anesthesia and Respiratory Devices Market
42. Sweden Anesthesia and Respiratory Devices Market
42. Switzerland Anesthesia and Respiratory Devices Market
43. Eastern Europe Anesthesia and Respiratory Devices Market
44. Russia Anesthesia and Respiratory Devices Market
45. Czech Republic Anesthesia and Respiratory Devices Market
46. Poland Anesthesia and Respiratory Devices Market
47. Romania Anesthesia and Respiratory Devices Market
48. Ukraine Anesthesia and Respiratory Devices Market
49. North America Anesthesia and Respiratory Devices Market
50. USA Anesthesia and Respiratory Devices Market
51. Canada Anesthesia and Respiratory Devices Market
52. Mexico Anesthesia and Respiratory Devices Market
53. South America Anesthesia and Respiratory Devices Market
54. Brazil Anesthesia and Respiratory Devices Market
55. Chile Anesthesia and Respiratory Devices Market
56. Argentina Anesthesia and Respiratory Devices Market
57. Colombia Anesthesia and Respiratory Devices Market
58. Peru Anesthesia and Respiratory Devices Market
59. Middle East Anesthesia and Respiratory Devices Market
60. Saudi Arabia Anesthesia and Respiratory Devices Market
61. Israel Anesthesia and Respiratory Devices Market
62. Iran Anesthesia and Respiratory Devices Market
63. Turkey Anesthesia and Respiratory Devices Market
64. United Arab Emirates Anesthesia and Respiratory Devices Market
65. Africa Anesthesia and Respiratory Devices Market
66. Egypt Anesthesia and Respiratory Devices Market
67. Nigeria Anesthesia and Respiratory Devices Market
68. South Africa Anesthesia and Respiratory Devices Market
70. Anesthesia and Respiratory Devices Market Competitive Landscape and Company Profiles
71. Anesthesia and Respiratory Devices Market Other Major and Innovative Companies
74. Anesthesia and Respiratory Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Anesthesia And Respiratory Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses anesthesia and respiratory devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for anesthesia and respiratory devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anesthesia and respiratory devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Respiratory Devices And Equipment (Therapeutic And Diagnostic); Anesthesia Machines; Anesthesia Disposables; Respiratory Disposables2) By Type Of Expenditure: Public; Private
3) By Category: Instruments Or Equipment; Disposables
4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Respiratory Devices And Equipment (Therapeutic And Diagnostic): Therapeutic Devices (Oxygen Therapy Devices; CPAP Or BiPAP Machines); Diagnostic Devices (Spirometers, Pulse Oximeters, Peak Flow Meters); Nebulizers2) By Anesthesia Machines: Continuous Flow Anesthesia Machines; Portable Anesthesia Machines; Anesthesia Workstations
3) By Anesthesia Disposables: Anesthesia Masks; Endotracheal Tubes; Laryngeal Mask Airways (LMAs); Breathing Circuits
4) By Respiratory Disposables: Oxygen Masks; Ventilator Circuits; Filters And HME (Heat And Moisture Exchangers); Suction Catheters
Companies Mentioned: Drägerwerk AG & Co KGaA; GE Healthcare; Koninklijke Philips N V; Medtronic plc; ResMed Inc.; Fisher & Paykel Healthcare Corporation Limited; Smiths Medical plc; Masimo Corporation; B Braun Melsungen AG; Shenzhen Mindray Bio‑Medical Electronics Co Ltd; Hamilton Medical AG; Nihon Kohden Corporation; Ambu A S; Invacare Corporation; SunMed Medical; Intersurgical Ltd; PARI GmbH; Heinen + Löwenstein GmbH & Co KG; Aerogen Ltd; DeVilbiss Healthcare LLC
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Anesthesia and Respiratory Devices market report include:- Drägerwerk AG & Co KGaA
- GE Healthcare
- Koninklijke Philips N V
- Medtronic plc
- ResMed Inc.
- Fisher & Paykel Healthcare Corporation Limited
- Smiths Medical plc
- Masimo Corporation
- B Braun Melsungen AG
- Shenzhen Mindray Bio‑Medical Electronics Co Ltd
- Hamilton Medical AG
- Nihon Kohden Corporation
- Ambu A S
- Invacare Corporation
- SunMed Medical
- Intersurgical Ltd
- PARI GmbH
- Heinen + Löwenstein GmbH & Co KG
- Aerogen Ltd
- DeVilbiss Healthcare LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 42.45 Billion |
| Forecasted Market Value ( USD | $ 70.71 Billion |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
